Sangamo Therapeutics Inc (NASDAQ: SGMO) is making a run for the top in the market this morning, and for good reason. The company announced data from a Phase 1/2 trial that it is working on with Pfizer (PFE). The data release proved to be positive, exciting investors and sending the stock screaming for the top. … Read more
Sangamo Therapeutics Inc (NASDAQ: SGMO) is climbing in the market this morning. However, if you’re looking for press releases or SEC filings from the company, you’re out of luck. There’s none out there. That doesn’t mean that this climb in value is without a catalyst. In fact, there’s a very good reason for the gains. … Read more
Sangamo Therapeutics Inc (NASDAQ: SGMO) made a huge announcement early this monring. The company announced that it will be making an offering to acquire TxCell, leading to excitement and getting the social investing community buzzing. Today, we’ll talk about: The acquisition news; why the news is so exciting; and what we’ll be watching for ahead. … Read more
Sangamo Therapeutics Inc (NASDAQ: SGMO) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has entered into a collaboration agreement, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about the news, what we’re seeing from SGMO … Read more
Sangamo Therapeutics Inc (NASDAQ: SGMO) is off to an incredibly strong start in the pre-market hours today, and for good reason, the company announced that it has received Fast Track Designation from the FDA. As a result, investor excitement ensued, leading to gains in the stock and prompting our partners at Trade Ideas to alert … Read more
Sangamo Therapeutics Inc (NASDAQ: SGMO) Sangamo Therapeutics is having an overwhelmingly strong start to the trading session today, and for good reason. Data from an animal model showed strong results with regard to one of their pre-clinical treatment prospects. As a result, investors showed their excitement, leading to gains and an alert from our partners … Read more